GUATEMALA KIMBLE: Open Payments
NPI 1427593326 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$704 in 35 payments from 13 companies in 2025. Trend: 2023 $98 · 2024 $160 · 2025 $704
Food & beverage: $704
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $241 |
| Ardelyx, Inc. | 4 | $107 |
| Phathom Pharmaceuticals, Inc. | 4 | $81 |
| GENZYME CORPORATION | 2 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $43 |
| Janssen Biotech, Inc. | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $32 |
| PFIZER INC. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
Products named: RINVOQ, IBSRELA, LINZESS, VOQUEZNA, DUPIXENT, XIFAXAN, TREMFYA, CREON.
Industry payments across GA — which companies pay providers there.
